Something big is brewing up for ICO As everyone observed, about 22 million shares were traded during last Monday and Tuesday with the price reaching 0.07. From last Wednesday to today, another ~7.5 million shares were traded at 0.045 and above. No doubt, something big is brewing up.
Get on the boat at current share price of 0.045-0.05, I can sleep easy even with a few cents up or down.
ICO has enough cash for to last close to 1.5 years without dilution. Think about that? It means that if anyone can buy the stock at say 5 or 5.5 cents and if it goes up even once in 1.5 years he has made money. Is that simple and clear?
I personally like the odds especially with the events and news that is to come anytime from now on.
Cash and equivalent $2.643 million without debts at the end of September 2016.
"After the third quarter end, we also announced a world-wide exclusive option to a novel glaucoma candidate and we continue to discuss further complimentary additions to our ophthalmology pipeline with multiple parties. We estimate our runway to extend to Q2 2018 based on the current burn rate and we expect to report additional milestones during the remainder of 2016 and in early 2017". stated Andrew Rae, President and CEO (quoted from the financial report released in November 24, 2016).
The following calendar was posted by Gui114me in March 19, 2017 (please check it on this bullboard): (1) Amp B: Additional non-dilutive grant funding Q4/2016 – DONE; (2) Amp B: Positive pre clinical study results using optimized formulation Q4/2016 – DONE; (3) iCo-008: Phase 2 clinical data (UC, BP) H1 2017; (4) Amp B: Phase 1A clinical study completion H2 2017; (5) Salvat Completion of diligence, meeting with FDA or comparable regulatory Option: agency regarding clinical path Mid 2017.
Do your own d.d.